Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medsurge Healthcare is a specialty pharmaceutical company based in Australia that focuses on the registration, marketing, and distribution of niche and essential medicines. The company is a significant player in the Australian pharmaceutical landscape, particularly known for providing access to unregistered medicines through the Special Access Scheme (SAS) and Authorized Prescriber pathways. Their portfolio spans several critical therapeutic areas, including oncology, hematology, and rare diseases, and includes both registered generic products and specialty branded therapeutics. Medsurge offers end-to-end commercialization services, including regulatory affairs, medical information, and specialized cold-chain logistics to ensure the delivery of high-quality healthcare solutions to the Australian and New Zealand markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medsurge Medical.